Cancer Research UK Cambridge Institute

The Cancer Research UK Cambridge Institute aims to bring the scientific strengths of Cambridge to bear on practical questions of cancer diagnosis, treatment and prevention. The Institute focuses specifically on the practical application of high-quality basic research.

About us

Latest news

  • News

    Dr Raza Ali joins Institute as new Group Leader

    We are delighted to announce that Dr Raza Ali will be joining the Institute as a new Junior Group Leader in early 2020. Raza studied Medicine at Cardiff University, later specialising in Histopathology before joining the Caldas Group for his PhD as a Clinical Research Fellow. After completing his PhD, he was granted an NIHR […]

    Find out more
  • News

    Institute researchers to work on €30 million Immune-Image consortium

    Prof Kevin Brindle Dr Maike de la Roche   Professor Kevin Brindle and Dr Maike De la Roche to play key roles in a new €30 million Innovative Medicines Initiative grant, supporting research into novel tracer strategies for clinical imaging of immune cell dynamics. The introduction of immunotherapies for the treatment of cancer and inflammatory disease, where the drugs […]

    Find out more
  • News

    UK-Japan collaboration to understand epigenomes and ageing

    The Narita Group have been awarded £490,000 to study epigenomes and ageing from the UK Research and Innovation (UKRI) Fund for International Collaboration, in a joint call with the Japan Society for the Promotion of Science (JSPS). Professor Masashi Narita’s Group study how to permanently stop the growth of tumour cells. In response to internal […]

    Find out more
  • News

    Highly sensitive blood test could improve breast cancer treatment

    A new, highly sensitive blood test is one of the first to successfully monitor breast cancer patients with early stage disease and could be up to 100 times more sensitive than existing tests, according to a study published in Science Translational Medicine. Researchers at the Translational Genomics Research Institute (TGen) and the Mayo Clinic in […]

    Find out more

Who we work with